In most studies, hypomethylation of CpG sites in the region of SNCA intron 1 was found [26,27,28,29,30,31], but there are also opposite data, where differences between groups of patients with PD and controls could not be identified [32,33,34]. The gene discussed is SNCA; the disease is Parkinson disease.